C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2006
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264431 P38 inhibitors and methods of use thereof
11/23/2006	US20060264430 Pyrazole derivative
11/23/2006	US20060264428 Tri-, tetra-substituted-3-aminopyrrolidine derivative
11/23/2006	US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006	US20060264425 Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	US20060264417 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
11/23/2006	US20060264415 Inhibitors of histone deacetylase
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	DE102005023207A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006	DE102005019718A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608766A1 2-amino-4-phenylquinazoline derivatives and the use thereof as hsp90 modulators
11/23/2006	CA2608718A1 1, 2, 4-triazole derivatives as vasopressin antagonists
11/23/2006	CA2608240A1 Multicyclic compounds and methods of their use
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724323A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1723139A1 Cell targeting conjugates
11/22/2006	EP1723138A1 Substituted benzimidazoles and their use for inducing apoptosis
11/22/2006	EP1723137A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723120A1 Ion channel modulators
11/22/2006	EP1723119A1 Ion channel modulators
11/22/2006	EP1723117A2 Ion channel modulators
11/22/2006	EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006	EP1722796A2 Tetracyclic lactam derivatives and uses thereof
11/22/2006	EP1722788A2 Ion channel modulators
11/22/2006	EP1722787A1 Ion channel modulators
11/22/2006	EP1722785A1 Ion channel modulators
11/22/2006	EP1722784A2 Ion channel modulators
11/22/2006	EP1722783A2 Ion channel modulators
11/22/2006	EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867563A Novel imidazole derivatives and their use as pharmaceutical agents
11/22/2006	CN1867562A Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867547A Compounds having crth2 antagonist activity
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285605C Antitumour indolo pyrrolo carbazole derivatives
11/22/2006	CN1285589C Heterocyclic compound containing double pyrazole, preparing method and its use
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285575C Heterocyclic thioesters and ketones
11/21/2006	US7138526 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
11/21/2006	US7138421 Anti-androgenic pyrrolidines with tumor-inhibiting action
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138392 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
11/21/2006	US7138361 Herbicidal heterocycles
11/21/2006	CA2199226C Process for the preparation of unsymmetrical 4,6-bis(aryloxy)pyrimidine compounds
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/16/2006	WO2006122254A2 Stable micronized candesartan cilexetil and methods for preparing thereof
11/16/2006	WO2006122014A2 Bicyclic derivatives as modulators of ion channels
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006120427A1 Affinity adsorbents for factor viii and von willebrand's factor
11/16/2006	WO2006083424A3 Radiolabeled compounds and uses thereof
11/16/2006	WO2006002895A3 Conjugates of antibody and duoarmycin derivatives as antitumor agents
11/16/2006	US20060258863 Synthesis of CCR5 antagonists
11/16/2006	US20060258861 Respiratory or gastrointestinal disorders; cancer
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258727 Olmesartan medoxomil with reduced levels of impurities
11/16/2006	US20060258726 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258717 Organic compounds
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258706 Solid forms of a JNK inhibitor
11/16/2006	US20060258694 Anticancer agents; antiinflammatory agents; skin disorders; inflamamtory bowel disorders; vision defects; Alzheimer's disease
11/16/2006	US20060258681 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
11/16/2006	US20060258678 Novel indole derivatives
11/16/2006	US20060258677 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258676 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258675 Novel crystalline forms of gatofloxacin and processes for preparation
11/16/2006	US20060258674 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258673 Process of making crystalline Type II aripiprazole
11/16/2006	US20060258672 Multicyclic compounds and methods of their use
11/16/2006	US20060258671 Phenylpyridylpiperazine compounds
11/16/2006	US20060258670 New phenylpyridylpiperazine compounds
11/16/2006	US20060258669 Therapeutic agents useful for treating pain
11/16/2006	US20060258666 c-fms kinase inhibitors
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	US20060258638 Succinoylamino lactams as inhibitors of A-beta protein production
11/16/2006	US20060257917 Fluorescent dyes, energy transfer couples and methods
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 626